JP4694657B2 - 新規外部寄生生物唾液タンパク質および同タンパク質を収集する装置 - Google Patents

新規外部寄生生物唾液タンパク質および同タンパク質を収集する装置 Download PDF

Info

Publication number
JP4694657B2
JP4694657B2 JP53649997A JP53649997A JP4694657B2 JP 4694657 B2 JP4694657 B2 JP 4694657B2 JP 53649997 A JP53649997 A JP 53649997A JP 53649997 A JP53649997 A JP 53649997A JP 4694657 B2 JP4694657 B2 JP 4694657B2
Authority
JP
Japan
Prior art keywords
seq
sequence
nucleic acid
protein
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP53649997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000509972A5 (enExample
JP2000509972A (ja
Inventor
フンター、シアリー・ウー
― ケー シム、ゲック
ウェーバー、エリック・アール
Original Assignee
ヘスカ・コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヘスカ・コーポレーション filed Critical ヘスカ・コーポレーション
Publication of JP2000509972A publication Critical patent/JP2000509972A/ja
Publication of JP2000509972A5 publication Critical patent/JP2000509972A5/ja
Application granted granted Critical
Publication of JP4694657B2 publication Critical patent/JP4694657B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/22—Devices for withdrawing samples in the gaseous state
    • G01N1/24—Suction devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/4359—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from fleas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Insects & Arthropods (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP53649997A 1996-04-10 1997-04-10 新規外部寄生生物唾液タンパク質および同タンパク質を収集する装置 Expired - Fee Related JP4694657B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/630,822 US5840695A (en) 1994-10-07 1996-04-10 Ectoparasite saliva proteins and apparatus to collect such proteins
US08/630,822 1996-04-10
PCT/US1997/005959 WO1997037676A1 (en) 1996-04-10 1997-04-10 Novel ectoparasite saliva proteins and apparatus to collect such proteins

Publications (3)

Publication Number Publication Date
JP2000509972A JP2000509972A (ja) 2000-08-08
JP2000509972A5 JP2000509972A5 (enExample) 2004-12-09
JP4694657B2 true JP4694657B2 (ja) 2011-06-08

Family

ID=24528687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53649997A Expired - Fee Related JP4694657B2 (ja) 1996-04-10 1997-04-10 新規外部寄生生物唾液タンパク質および同タンパク質を収集する装置

Country Status (9)

Country Link
US (3) US5840695A (enExample)
EP (1) EP0939642A4 (enExample)
JP (1) JP4694657B2 (enExample)
AR (1) AR008588A1 (enExample)
AU (1) AU719742B2 (enExample)
CA (1) CA2250835C (enExample)
IL (1) IL120620A0 (enExample)
WO (1) WO1997037676A1 (enExample)
ZA (1) ZA973023B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840695A (en) * 1994-10-07 1998-11-24 Heska Corporation Ectoparasite saliva proteins and apparatus to collect such proteins
US6485968B1 (en) * 1994-10-07 2002-11-26 Heska Corporation Ectoparasite saliva proteins and apparatus to collect such proteins
US20020169104A1 (en) * 1997-05-01 2002-11-14 Glenn Frank Novel ectoparasite saliva proteins and apparatus to collect such proteins
US6576238B1 (en) * 1994-10-07 2003-06-10 Heska Corporation Ectoparasite saliva proteins and apparatus to collect such proteins
US20020142352A1 (en) * 1999-03-04 2002-10-03 Heska Corporation Novel ectoparasite salvia proteins and apparatus to collect such proteins
EP1947112B1 (en) * 1999-04-09 2012-05-16 Heska Corporation Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
CA2372028A1 (en) * 1999-04-09 2000-10-19 Heska Corporation Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
EP1710252A3 (en) * 1999-04-09 2006-12-27 Heska Corporation Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
AU7878900A (en) * 1999-10-15 2001-04-30 Heska Corporation Method for production and use of mite group 1 proteins
PL359920A1 (en) * 2000-09-20 2004-09-06 Merck Patent Gmbh 4-amino-quinazolines
US20040044204A1 (en) * 2000-09-20 2004-03-04 Werner Mederski 4-amino-quinazolines
CA2429372A1 (en) * 2001-01-03 2002-08-29 Heska Corporation Detection of allergen-specific ige
PE20020958A1 (es) * 2001-03-23 2002-11-14 Bayer Corp Inhibidores de la rho-quinasa
HN2002000067A (es) * 2001-03-23 2003-10-24 Bayer Healthcare Llc Inhibidores de la rho - quinasa.
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US7829566B2 (en) * 2001-09-17 2010-11-09 Werner Mederski 4-amino-quinazolines
EP1465900B1 (en) * 2002-01-10 2008-05-14 Bayer HealthCare AG Rho-kinase inhibitors
US20030157555A1 (en) * 2002-01-14 2003-08-21 Lipps Binie V. Diagnosis and treatment for immunoglobulin E ( IgE) implicated disorders
MXPA04007191A (es) * 2002-01-23 2005-03-31 Bayer Pharmaceuticals Corp Derivados de pirimidina como inhibidores de rho-quinasa.
CA2473910C (en) * 2002-01-23 2011-03-15 Bayer Pharmaceuticals Corporation Pyrimidine derivatives as rho-kinase inhibitors
US20050053615A1 (en) * 2003-07-16 2005-03-10 Best Elaine A. Variants of mite group 1 allergens for the treatment of house dust mite allergy
ATE473440T1 (de) * 2005-07-27 2010-07-15 Cytosignet Inc Nachweis und messung einer blutzuführungsaktivität
EP1754717A1 (en) * 2005-08-19 2007-02-21 Université de Lausanne Antigenic peptides and their use
CN100374152C (zh) * 2005-12-23 2008-03-12 中国农业大学 一种过敏性反应抑制剂
WO2007111937A1 (en) * 2006-03-23 2007-10-04 Applera Corporation Directed enrichment of genomic dna for high-throughput sequencing
US8028437B2 (en) * 2006-12-19 2011-10-04 Pauline Brown-Carter Hair dryer and vacuum device
CA3050253A1 (en) * 2017-01-16 2018-07-19 AgBiome, Inc. Methods and compositions for feeding piercing and sucking insects

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356622A (en) * 1991-12-13 1994-10-18 Paravax, Inc. Flea midgut-supernatant vaccines
WO1993018788A1 (en) * 1992-03-24 1993-09-30 The University Of Queensland An antigen for diagnosis and hyposensitisation of flea allergy dermatitis in animals
US5840695A (en) * 1994-10-07 1998-11-24 Heska Corporation Ectoparasite saliva proteins and apparatus to collect such proteins
EP0784682B1 (en) * 1994-10-07 2004-04-28 Heska Corporation Novel ectoparasite saliva proteins and apparatus to collect such proteins
WO1996014089A1 (en) 1994-11-03 1996-05-17 Zoogen, Inc. Methods and compositions for the diagnosis of flea allergies
AUPN012594A0 (en) * 1994-12-16 1995-01-19 Powerbeam Pty Ltd Strengthening of poles
WO1996028469A1 (en) 1995-03-09 1996-09-19 Heska Corporation Hematophagous insect calreticulin nucleic acid molecules, proteins and uses thereof

Also Published As

Publication number Publication date
WO1997037676A1 (en) 1997-10-16
IL120620A0 (en) 1997-08-14
US6368846B1 (en) 2002-04-09
CA2250835A1 (en) 1997-10-16
AU2453197A (en) 1997-10-29
US5932470A (en) 1999-08-03
JP2000509972A (ja) 2000-08-08
AU719742B2 (en) 2000-05-18
EP0939642A4 (en) 2003-06-18
ZA973023B (en) 1997-11-04
AR008588A1 (es) 2000-02-09
EP0939642A1 (en) 1999-09-08
CA2250835C (en) 2013-07-23
US5840695A (en) 1998-11-24

Similar Documents

Publication Publication Date Title
CA2250835C (en) Novel ectoparasite saliva proteins and apparatus to collect such proteins
US5795862A (en) Ectoparasite saliva proteins and apparatus to collect such proteins
US20080038205A1 (en) Novel dermatophagoides proteins
JP2007181463A (ja) 新規な外部寄生生物唾液タンパク質及びそのようなタンパク質を収集する装置
WO1996011271A9 (en) Novel ectoparasite saliva proteins and apparatus to collect such proteins
US5952194A (en) Flea nucleic acid sequences and uses thereof
US7629446B2 (en) Nucleic acid molecules encoding a novel ectoparasite saliva protein
US20080045693A1 (en) Novel flea saliva protein
US8268976B2 (en) Flea GABA receptor subunit nucleic acid molecules
US7128921B1 (en) Dermatophagoides proteins and fragments thereof
WO1996028469A1 (en) Hematophagous insect calreticulin nucleic acid molecules, proteins and uses thereof
WO2002022807A2 (en) Dermatophagoides nucleic acid molecules, proteins and uses thereof
IL115540A (en) Compositions comprising selected ectoparasite saliva proteins
MXPA97002529A (en) Novedosas proteins of saliva of ectoparasito, yaparato for the obtaining of such protei

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040412

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040412

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080422

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080722

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100217

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100517

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110125

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110224

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140304

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees